High expression of PD-L2 was associated with a poor prognostic in patients diagnosed with hepatocellular carcinoma, while no association was observed in patients diagnosed with gastric, renal cell carcinoma, and esophageal cancer [28]. Here, PDCD1LG2 is linked to hepatocellular carcinoma.